Scroll To Top
Treatment

The Future of HIV Treatment May be Injectable Medication

The Future of HIV Treatment May be Injectable Medication

Injectablex400

Will you someday ditch your pills for a weekly shot to treat HIV?

Soon it may be possible to treat HIV with a weekly injection instead of pills.

Biotech firm CytoDyn plans a Phase III study — the final test before seeking Food and Drug Administration approval — of PRO 140, the first self-injectable antibody to treat HIV. The 25-week trial will involve 300 HIV-positive patients.

If approved, PRO 140, which has already shown ability to suppress the virus, will compete with Selzentry (both target the same protein, CCR%, thus preventing the entry of HIV into T cells), but PRO 140 appears to be less toxic, with fewer side effects. A Phase IIb study documented a 98 percent success rate for the drug in viral suppression, and it has the potential to treat other disorders, including certain inflammatory diseases, autoimmunity, and cancer, according to CytoDyn. The company intends to submit its final application to the FDA in November 2016, with PRO 140 going on the market in 2017, if the Phase III results are positive.

Advocate Channel - The Pride StoreOut / Advocate Magazine - Fellow Travelers & Jamie Lee Curtis

From our Sponsors

Most Popular

Latest Stories

Trudy Ring

Editor

Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.

Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.